Methyl 4-fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 97%, 250mg

(S)-tert-Butyl 6-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-aminohexanoate hydrochloride, 98%, 25g

Glutaronitrile, 95.0%, 25g

3-Chloro-2-fluorophenylacetic acid, 95.0%, 5g

8-methyl-4-(2,4,6-trimethylbenzoyl)-1-oxa-4-azaspiro[4.5]decane-3-carboxylic acid, 95.0%, 2g

4,6-Dichloro-2-cyclopropylpyrimidine, 95.0%, 10g

6-(1H-Pyrazol-1-yl)nicotinonitrile, 95.0%, 250mg

Ácido 5-fluoroorótico, mínimo 98 %, para bioquímica, 2,5 g, envase de vidrio

4-(m-Tolylamino)pyridine-3-sulfonamide, 95.0%, 10g

5-CHLORO-3-METHOXYPYRIDAZINE, 95%, 250mg

Ethyl 2-(Bromomethyl)acrylate (stabilized with HQ)>97.0%(GC)5g

Lámina de cobre (OFHC) 99,95+% 2 x 50 x 50 mm 1 ud.

2-(5-Fluoro-2-methoxypyridin-3-yl)acetonitrile, 98%, 250mg